ARTICLE | Clinical News
Immunomedics regulatory update
January 4, 1999 8:00 AM UTC
The FDA granted Orphan Drug designation for IMMU's CEA-Cide, a humanized monoclonal antibody against the carcinoembryonic antigen, to treat pancreatic cancer. ...
The FDA granted Orphan Drug designation for IMMU's CEA-Cide, a humanized monoclonal antibody against the carcinoembryonic antigen, to treat pancreatic cancer. ...